gilead sciences hiv - Search News

News

Gilead's bi-annual HIV prevention jab gets FDA approval

Gilead's bi-annual HIV prevention jab gets FDA approval: How much does it cost and how it works? All you need to know…

Gilead Sciences has received US FDA approval for Yeztugo, its bi-annual HIV prevention injection, which has shown 96 per cent effectiveness in trials. Here's how it works, and what it costs.

USA TODAY on MSN · 16h

FDA approves new twice-yearly HIV shot. What to know

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

STAT · 1d

Gilead’s CEO on the approval of a powerful new drug to prevent HIV

Gilead's CEO says he's committed to making sure people around the world can get his firm's new HIV prevention shot Yeztugo.

Pharmabiz5h

Gilead Sciences’ Yeztugo receives nod; the first and only US FDA-approved HIV prevention option offering 6 months of protection

Gilead Sciences’ Yeztugo receives nod; the first and only US FDA-approved HIV prevention option offering 6 months of protection: Foster City, California Friday, June 20, 2025, 1 ...

The Observer53m

Byanyima urges realistic price cut on Shs 100m/yr HIV prevention drug

General, Winnie Byanyima, has called for a drastic and transparent reduction in the cost of lenacapavir, a twice-yearly ...

Should You Buy Gilead Stock At $110?

Gilead Sciences (NASDAQ:GILD) has demonstrated a strong performance this year, with its stock up 18% compared to the S&P ...

CSRWire1d

Gilead Researcher Awarded the AAAS Mani L. Bhaumik Breakthrough of the Year Award

Gilead has been a leader in HIV innovation for decades. Now, we're proud to share that one of our researchers, Moupali Das, ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results